Hologic, Inc. http://www.alacrastore.com/company-snapshot/Hologic_Inc-1027540 28 Nov 2009 01:57:50 EST 1027540 Hologic, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T2504997T2504997ccbn/T2504997norm19 Nov 2009 01:05:39 EST2504997Final Transcript of HOLX presentation, 19-Nov-09 9:10am ETHologic106.0000FinalHologic at Citi Small/Mid Cap Conference TranscriptHOLX9:10am ETTranscript...So briefly this morning I will try to focus on what sets Hologic apart. Let me just start there. And number one, it really is the R&D that we bring to the table on all of our products. And that is why, when you run down the list of markets and products that we're in, we are number one. Breast-cancer screening, we have ##% of the US market. Cervical cancer screening, ##% of the US market. It goes on and on. Our focus continues to be on bringing leading-edge technology to the marketplace. But it is not just the technology. It is having the distribution in place to get that product to our customer. And for us we do have the largest dedicated women's health sales force in the United States. Over ### individuals selling our product. And this didn't happen overnight. We have been selling products in the US for over ## years. So we have built up a strong customer rapport and brand recognition. Our international distribution is continuing. We do have over ### people focused in sales outside of... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2372135B2372135ccbn/B2372135norm09 Nov 2009 09:06:00 EST2372135Edited Brief of HOLX earnings conference call or presentation, 9-Nov-09 5:00pm ETHologic54.0000EditedHologic Q4 2009 Earnings Conference Call SummaryHOLX5:00pm ETBrief...Deborah Gordon Hologic - VP, IR Jack Cumming Hologic - Chairman Rob Cascella Hologic - CEO Glen Muir Hologic - EVP, CFO Howard Doran Hologic - SVP/President - Diagnostic Products Tony Kingsley Hologic - SVP/Gen. Mngr. - GYN Surgical Products... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2372135T2372135ccbn/T2372135norm09 Nov 2009 07:06:00 EST2372135Final Transcript of HOLX earnings conference call or presentation, 9-Nov-09 5:00pm ETHologic54.0000FinalHologic Q4 2009 Earnings Conference Call TranscriptHOLX5:00pm ETTranscript...Deborah Gordon Hologic - VP, IR Jack Cumming Hologic - Chairman Rob Cascella Hologic - CEO Glen Muir Hologic - EVP, CFO Howard Doran Hologic - SVP/President - Diagnostic Products Tony Kingsley Hologic - SVP/Gen. Mngr. - GYN Surgical Products... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39566334BW-0001-39566334newstex/BW-0001-39566334xmlNewstex Inc.2005Conceptus, Inc.Newstex Inc.newstex.comnewstexBW-0001-39566334Business Wire0001Business WireBW1Newstex Inc.Business Wire1400000014007000020000000200200002002006020020040200200804000000040020000400200609 Nov 2009 05:22:10 EST18000000180180001900000019001000190020001900201311/9/2009 Nov. #, #### (Business Wire) -- Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure ® procedure, the first proven non-incisional permanent birth control method available, today announced that the United Stated District Court, Northern...CONCEPTUS INCHOLOGIC INCMARK M SIECZKAREKCPTSHOLXNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T2400942T2400942ccbn/T2400942norm15 Sep 2009 09:06:00 EST2400942Final Transcript of HOLX presentation, 15-Sep-09 2:45pm ETHologic54.0000FinalHologic at Morgan Stanley Global Healthcare Conference TranscriptHOLX2:45pm ETTranscript...Marshall Urist - Morgan Stanley - Analyst Good afternoon, everyone. I'm Marshal Urist with the medtech team sitting in for David Lewis, who was double booked this afternoon. So we are happy to be here with Glenn Muir with Hologic. And before we get started Glenn, why don't you give an overview, sort of a five minute overview of the Company for anyone in the audience not necessarily familiar with the story. Glenn Muir - Hologic - CFO, EVP Fin. & Admin., Assistant Sec., Treasurer Great. Thank you, Marshall. Maybe I could start off a little bit at where we are at this point in the year. We -- this is September for us, we are a fiscal September year-end Company. So this is the end of our fiscal ####. And I must say it's been somewhat of a challenging year FY '##, especially as it relates to the capital equipment pieces of our business. I think Hologic is well known as the leader in digital mammography. Our flagship product is our Selenia product. And it has been a challenge. The economy and... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/moodys/COP_820320622COP_820320622moodys/COP_820320622html20 Aug 2009 04:58:22 ESThtmlHologic, Inc.Hologic, Inc.820320622150.000019 Aug 2009NewsCredit OpinionCGlobal Credit Research Credit Opinion ## AUG #### Credit Opinion: Hologic, Inc. Hologic, Inc. Bedford, Massachusetts, United States Ratings Category Moody's Rating Outlook Stable Corporate Family Rating Ba# Sr Sec Bank Credit Facility...Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T2273262T2273262ccbn/T2273262norm13 Aug 2009 10:06:00 EST2273262Final Transcript of HOLX presentation, 13-Aug-09 8:30am ETHologic54.0000FinalHologic at CanaccordAdams Global Growth Conference TranscriptHOLX8:30am ETTranscript...we will be there when those markets open up. We do have ### people outside the US focused in these areas, but we do sell primarily through dealers and distributors and we have over ### dealers and distributors focused in over ### different countries. We have added a number of -- or have made a number of acquisitions over the past few years. What do we look for? I think number one, we look for product offerings that we can add to our current portfolio. And that is really number one as we expand the number of products that our sales force can offer to our customers. But number two, we've looked for acquisitions that at the same time have expanded our sales force to give us additional breadth and leverage. And then number three, and this underscores every acquisition we've looked at in every deal that we've ever made, is that company has to bring to bear some type of advanced technology that we can incorporate into our product or that we can further develop with our own R&D. Another differentiator... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2327093B2327093ccbn/B2327093norm03 Aug 2009 09:06:00 EST2327093Edited Brief of HOLX earnings conference call or presentation, 3-Aug-09 5:00pm ETHologic54.0000EditedHologic Q3 2009 Earnings Conference Call SummaryHOLX5:00pm ETBrief...Deborah Gordon Hologic - VP IR Jack Cumming Hologic - Chairman, CEO Glenn Muir Hologic - EVP, CFO Rob Cascella Hologic - President, COO Howard Doran Hologic - SVP, Diagnostic Products Tony Klingsley Hologic - Head of Surgical Group CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2327093T2327093ccbn/T2327093norm03 Aug 2009 07:06:00 EST2327093Final Transcript of HOLX earnings conference call or presentation, 3-Aug-09 5:00pm ETHologic54.0000FinalHologic Q3 2009 Earnings Conference Call TranscriptHOLX5:00pm ETTranscript...Deborah Gordon Hologic - VP IR Jack Cumming Hologic - Chairman, CEO Glenn Muir Hologic - EVP, CFO Rob Cascella Hologic - President, COO Howard Doran Hologic - SVP, Diagnostic Products Tony Klingsley Hologic - Head of Surgical Group C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/bir/213873213873bir/213873norm217Hologic Inc.Direct Radiography Corp.FluoroScan Imaging Systems Inc.Trex Medical Corp.Continental X-Ray Corp.Cytyc Corp.Proxima Therapeutics Inc.Cytyc Health Corp.Cytyc Interim Inc.Novacept Inc.United States18 Jul 2009 06:13:00 ESTManufacturing: Manufactures osteoporosis diagnostic, x-ray imaging devices for orthopedic procedures.NASDAQ334517K3844GHOLXManufacturing: Manufactures osteoporosis diagnostic, x-ray imaging devices for orthopedic procedures.Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/spcred/732012732012spcred/732012normglobal06 Jul 2009 01:00:00 EST100NewsThe latest News from S&PUnited StatesHealth Care EquipmentUnited StatesGlobal IssuersNewsUSA43644043644A35101010 351010 3510 35Hologic Inc.419885USAHOLXNEWSCORPGLOBISSHealthLEVFINCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/730911730911spcred/730911normglobal30 Jun 2009 12:59:00 EST175SummaryThe latest Summary from S&PUnited StatesHealth Care EquipmentUnited StatesGlobal IssuersSummaryUSA43644043644A35101010 351010 3510 35Hologic Inc.419885USAHOLXSUMMARYCORPGLOBISSHealthLEVFINCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/730905730905spcred/730905normglobal30 Jun 2009 12:59:00 EST400Full ReportThe latest Full Report from S&PUnited StatesHealth Care EquipmentUnited StatesGlobal IssuersFull ReportUSA43644043644A35101010 351010 3510 35Hologic Inc.419885HOLXCORPGLOBISSHealthLEVFINFULLUSACredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T2235222T2235222ccbn/T2235222norm17 Jun 2009 06:04:00 EST2235222Final Transcript of HOLX presentation, 17-Jun-09 4:15pm ETHologic54.0000FinalHologic at Jefferies & Co. Healthcare Conference TranscriptHOLX4:15pm ETTranscript...Peter Bye - Jefferies & Co. - Analyst Now last but not least presentation today, Hologic. I'm pleased to introduce CFO Glenn Muir, and he's here to tell us why we should be buying the stock. Glenn Muir - Hologic - EVP, CFO Thank you, Peter. And thank you, everyone, for staying for the #:##. Peter told me earlier he liked to save all his best ideas for last. I will be making a lot of market-moving statements today, so Peter asked me to go after the market closed. The forward-looking statements, GAAP. Hologic -- we are one of the leading companies in the area of women's health. Our products cover a whole spectrum of women's health diseases, including breast cancer, cervical cancer, osteoporosis. Our desire is to treat and offer the full continuum of care to women today. Our products are best in class products. We consider them to be the gold standard in the marketplace today. They typically ... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2235319T2235319ccbn/T2235319norm10 Jun 2009 04:07:00 EST2235319Final Transcript of HOLX presentation, 10-Jun-09 3:00pm ETHologic54.0000FinalHologic at Needham & Company Biotechnology & Medical Technology Conference TranscriptHOLX3:00pm ETTranscript...Now the drivers in the US is simply the aging of the population. I think that is the number one driver for us, especially for things such as breast cancer, osteoporosis, cervical cancer. But in addition to that, advanced screening improved outcomes. We are all about finding better screening modalities to help catch cancers early. We are pushing for less invasive, less costly therapies. We want to move away from open surgical procedures such as in the breast biopsy world and move to minimally invasive procedures. And then finally, technological advancements. This is a big part of what Hologic does. It's to try to obsolete the products that we have today. The recent example that we are working on is #-D tomosynthesis hopefully to replace the #-D digital products in the market today, which replaced the analog film from years ago. If you look at a number of our products within the various segments that we have, you find that many of them are ranked number one. And the primary reason -- well,... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2115630B2115630ccbn/B2115630norm04 May 2009 08:06:00 EST2115630Edited Brief of HOLX earnings conference call or presentation, 4-May-09 5:00pm ETHologic54.0000EditedHologic Q2 2009 Earnings Conference Call SummaryHOLX5:00pm ETBrief...Tycho Peterson JPMorgan - Analyst David Lewis Morgan Stanley - Analyst Amit Bhalla Citigroup - Analyst Josh Jennings Jefferies & Company - Analyst Jayson Bedford Raymond James - Analyst Sameer Harish Needham & Company - Analyst Isaac Ro Leerink Swann Llc - Analyst Jonathan Block Suntrust Robinson Humphrey - Analyst OVERVIEW... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2115630T2115630ccbn/T2115630norm04 May 2009 07:06:00 EST2115630Final Transcript of HOLX earnings conference call or presentation, 4-May-09 5:00pm ETHologic54.0000FinalHologic Q2 2009 Earnings Conference Call TranscriptHOLX5:00pm ETTranscript...Tycho Peterson JPMorgan - Analyst David Lewis Morgan Stanley - Analyst Amit Bhalla Citigroup - Analyst Josh Jennings Jefferies & Company - Analyst Jayson Bedford Raymond James - Analyst Sameer Harish Needham & Company - Analyst Isaac Ro Leerink Swann Llc - Analyst Jonathan Block Suntrust Robinson Humphrey - Analyst P R E S E N T A T I O N... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/spcred/701106spcred/701106norm701106The latest News from S&Pglobal06 Feb 2009 12:57:00 EST100NewsUnited StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareNewsNEW YORK (Standard&Poor's) Feb. 6, 2009--Standard&Poor's Ratings Services said that it revised the outlook on Bedford, Mass.-based Hologic Inc. to stable from positive, as well as affirmed the ratings on the company, including the 'BB-' corporate credit rating. This action reflects the decline in Selenia digital mammography unit sales in the first quarter of fiscal 2009 (fiscal year-end Sept. 27, 2008) due to constrained hospital capital spending. We expect this trend, caused by the recession, to continue. As a result, financial parameters may not strengthen to levels that might otherwise suggest a higher near-term rating. "The mid-speculative-grade rating on Hologic reflects its concerns with the medical product company's aggressive growth, including the challenges of integrating newUSA43644A43644035101010 351010 3510 35Hologic Inc.419885USAHOLXNEWSGLOBISSCORPLEVFINHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/701107spcred/701107norm701107The latest Research Update from S&Pglobal06 Feb 2009 12:57:00 EST175Research UpdateUnited StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareResearch UpdateOn Feb. 6, 2009, Standard&Poor's Ratings Services said that it revised the outlook on Bedford, Mass.-based Hologic Inc. to stable from positive, as well as affirmed the ratings on the company, including the 'BB-' corporate credit rating. This action reflects the decline in Selenia digital mammography unit sales in the first quarter of fiscal 2009 (fiscal year-end Sept. 27, 2008) due to constrained hospital capital spending. We expect this trend, caused by the recession, to continue. As a result, financial parameters may not strengthen to levels that might otherwise suggest a higher near-term rating. The mid-speculative-grade rating on Hologic reflects its concerns with the medical product company's aggressive growth, including the challenges of integrating new activities, high debtUSA43644043644A35101010 351010 3510 35Hologic Inc.419885USAHOLXRESUPDGLOBISSCORPLEVFINHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/B2055231ccbn/B2055231normB2055231...Recession that has engulfed America has added a major challenge to this transition, especially given its speed, magnitude, and global consequences. ... 02 Feb 2009 08:06:00 ESTHologic54.0000EditedHologic Q1 2009 Earnings Conference Call SummaryHOLX5:00pm ETBriefCredit & Investment ResearchThomson StreetEvents